Drugs / MDCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01963455 | Jan 2013 → Aug 2014 | female stress incontinence | Royan Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01963455 ↗ |
| Modality | Cell therapy | “autologous muscle derived cells as therapy for stress urinary incontinence.” NCT01963455 ↗ |
| Route | Other | “paraurethral injection of MDCs” NCT01963455 ↗ |